Skip to main content
Top
Published in: Familial Cancer 1/2007

01-03-2007 | Original Paper

The interval between cancer diagnosis among mothers and offspring in a population-based cohort

Authors: Ora Paltiel, Yehiel Friedlander, Lisa Deutsch, Rebecca Yanetz, Ronit Calderon-Margalit, Efrat Tiram, Hagit Hochner, Micha Barchana, Susan Harlap, Orly Manor

Published in: Familial Cancer | Issue 1/2007

Login to get access

Abstract

Background

Familial cancers may be due to shared genes or environment, or chance aggregation. We explored the possibility that ascertainment bias influences cancer detection in families, bearing upon the time interval between diagnosis of affected mothers and offspring.

Methods

The Jerusalem Perinatal Study (JPS) comprises all mothers (n = 39,734) from Western Jerusalem who gave birth 1964 –1976 and their offspring (n = 88,829). After linking identification numbers with Israel’s Cancer Registry we measured the absolute time interval between initial cancer diagnoses in affected mother-offspring pairs. We tested the probability of obtaining intervals as short as those observed by chance alone, using a permutation test on the median interval.

Results

By June 2003 cancer had developed in 105 mother-offspring pairs within the cohort. Common sites among mothers were breast (47%), colorectal (9%), non-Hodgkin lymphoma (NHL) (8%) and cervix (7%), while for offspring in affected pairs common cancers were leukemia (12.4%), thyroid (13.3%), NHL (10.5%), breast (10.5%) and melanoma (7.6%). The median interval between diagnoses was 5.9 years, but for 33% of affected pairs the interval was ≤3 years. The probability of this occurring by chance alone was 0.03. This held true whether the offspring’s or mother’s diagnosis was first (P < 0.01).

Conclusions

In a population-based cohort followed for three decades, the absolute interval between the diagnosis of cancer in mothers and their offspring is shorter than expected by chance. Explanations include shared environmental exposures or the possibility that cancer ascertainment in one pair member affects health behaviors in the other resulting in early diagnosis. The latter may bias the estimation of anticipation and survival in familial cancers.
Literature
1.
go back to reference Hemminki K, Li X (2004) Familial risk in testicular cancer as a clue to a heritable environmental aetiology. Br J Cancer 90:1765–1770PubMedCrossRef Hemminki K, Li X (2004) Familial risk in testicular cancer as a clue to a heritable environmental aetiology. Br J Cancer 90:1765–1770PubMedCrossRef
2.
go back to reference Nagy R, Sweet K, Eng C (2004) Highly penetrant hereditary cancer syndromes. Oncogene 23:6445–6470PubMedCrossRef Nagy R, Sweet K, Eng C (2004) Highly penetrant hereditary cancer syndromes. Oncogene 23:6445–6470PubMedCrossRef
3.
go back to reference Li FP, Fraumeni JF (1969) Rhabdomyosarcoma in children: epidemiologic study and identification of a familial cancer syndrome. J Natl Cancer Inst 43:1365–1373PubMed Li FP, Fraumeni JF (1969) Rhabdomyosarcoma in children: epidemiologic study and identification of a familial cancer syndrome. J Natl Cancer Inst 43:1365–1373PubMed
4.
go back to reference Wiernik PH, Ashwin M, Hu X et al (2001) Anticipation in familial chronic lymphocytic leukemia. Brit J Haematol 113:407–414CrossRef Wiernik PH, Ashwin M, Hu X et al (2001) Anticipation in familial chronic lymphocytic leukemia. Brit J Haematol 113:407–414CrossRef
5.
go back to reference Shugart YY, Hemminki K, Vaittinen P et al (2001) Apparent anticipation and heterogeneous transmission patterns in familial Hodgkin’s and non-Hodgkin’s Lymphoma: report from a study based on Swedish cancer database. Leuk Lymphoma 42:407–415PubMedCrossRef Shugart YY, Hemminki K, Vaittinen P et al (2001) Apparent anticipation and heterogeneous transmission patterns in familial Hodgkin’s and non-Hodgkin’s Lymphoma: report from a study based on Swedish cancer database. Leuk Lymphoma 42:407–415PubMedCrossRef
6.
go back to reference Wiernik PH, Wang SQ, Hu X et al (2000) Age of onset evidence for anticipation in familial non-Hodgkin’s lymphoma. Brit J Haematol 108:72–79CrossRef Wiernik PH, Wang SQ, Hu X et al (2000) Age of onset evidence for anticipation in familial non-Hodgkin’s lymphoma. Brit J Haematol 108:72–79CrossRef
7.
go back to reference Rodriguez-Bigas MA, Lee PH, O’Malley L et al (1996) Establishment of a hereditary nonpolyposis colorectal cancer registry. Dis Colon Rectum 39:649–653PubMedCrossRef Rodriguez-Bigas MA, Lee PH, O’Malley L et al (1996) Establishment of a hereditary nonpolyposis colorectal cancer registry. Dis Colon Rectum 39:649–653PubMedCrossRef
8.
go back to reference Dagan E, Gershoni-Baruch R (2002) Anticipation in hereditary breast cancer. Clin Genet 62:147–150PubMedCrossRef Dagan E, Gershoni-Baruch R (2002) Anticipation in hereditary breast cancer. Clin Genet 62:147–150PubMedCrossRef
9.
go back to reference Harper PS, Harley HG, Reardon W et al (1992) Anticipation in myotonic dystrophy: new light on an old problem. Am J Hum Genet 51:10–16PubMed Harper PS, Harley HG, Reardon W et al (1992) Anticipation in myotonic dystrophy: new light on an old problem. Am J Hum Genet 51:10–16PubMed
10.
go back to reference Tsai YY, Petersen GM, Booker SV et al (1997) Evidence against genetic anticipation in familial colorectal cancer. Genet Epidemiology 14:435–446PubMedCrossRef Tsai YY, Petersen GM, Booker SV et al (1997) Evidence against genetic anticipation in familial colorectal cancer. Genet Epidemiology 14:435–446PubMedCrossRef
11.
go back to reference Goldin LR, Pfeiffer RM, Li X et al (2004) Familial risk of lymphoproliferative tumors in families of patients with chronic lymphocytic leukemia: results from the Swedish Family-Cancer Database. Blood 104:1850–1854PubMedCrossRef Goldin LR, Pfeiffer RM, Li X et al (2004) Familial risk of lymphoproliferative tumors in families of patients with chronic lymphocytic leukemia: results from the Swedish Family-Cancer Database. Blood 104:1850–1854PubMedCrossRef
13.
14.
go back to reference Olsen JH, Boice JD, Seersholm N et al (1995) Cancer in the parents of children with cancer. N Engl J Med 333:1594–1599PubMedCrossRef Olsen JH, Boice JD, Seersholm N et al (1995) Cancer in the parents of children with cancer. N Engl J Med 333:1594–1599PubMedCrossRef
15.
go back to reference Pang D, McNally R, Kelsey A et al (2003) Cancer incidence and mortality among the parents of a population-based series of 2604 children with cancer. Cancer Epidemiol Biomarkers Prev 12:538–544PubMed Pang D, McNally R, Kelsey A et al (2003) Cancer incidence and mortality among the parents of a population-based series of 2604 children with cancer. Cancer Epidemiol Biomarkers Prev 12:538–544PubMed
16.
go back to reference Hemminki K, Vaittinen P (1997) Effect of paternal and maternal cancer on cancer in the offspring: a population-based study. Cancer Epidemiol Biomarkers Prev 6:993–997PubMed Hemminki K, Vaittinen P (1997) Effect of paternal and maternal cancer on cancer in the offspring: a population-based study. Cancer Epidemiol Biomarkers Prev 6:993–997PubMed
17.
go back to reference Hemminki K, Li X, Plna K et al (2001) The Nation-wide Swedish Family-Cancer Database. Acta Onc 40:772–777CrossRef Hemminki K, Li X, Plna K et al (2001) The Nation-wide Swedish Family-Cancer Database. Acta Onc 40:772–777CrossRef
18.
go back to reference Dong C, Hemminki K (2001) Modification of cancer risks in offspring by sibling and parental cancers from 2,112,616 nuclear families. Int J Cancer 92:144–150PubMedCrossRef Dong C, Hemminki K (2001) Modification of cancer risks in offspring by sibling and parental cancers from 2,112,616 nuclear families. Int J Cancer 92:144–150PubMedCrossRef
19.
go back to reference Hemminki K, Mutanen P (2001) Parental cancer as a risk factor for nine common childhood malignancies. Br J Cancer 84:990–993PubMedCrossRef Hemminki K, Mutanen P (2001) Parental cancer as a risk factor for nine common childhood malignancies. Br J Cancer 84:990–993PubMedCrossRef
20.
go back to reference Grossman SA, Osman M, Hruban R et al (1999) Central nervous system cancers in first-degree relatives and spouses. Cancer Invest 17:299–308PubMedCrossRef Grossman SA, Osman M, Hruban R et al (1999) Central nervous system cancers in first-degree relatives and spouses. Cancer Invest 17:299–308PubMedCrossRef
21.
go back to reference Harlap S, Davies AM, Grover NB et al (1977) The Jerusalem perinatal study: the first decade 1964–73. Isr J Med Sci 13:1073–1091PubMed Harlap S, Davies AM, Grover NB et al (1977) The Jerusalem perinatal study: the first decade 1964–73. Isr J Med Sci 13:1073–1091PubMed
22.
go back to reference Davies AM, Prywes R, Tzur B et al (1969) The Jerusalem perinatal study. 1. Design and organization of a continuing, community-based, record linked survey. Isr J Med Sci 5:1095–1106PubMed Davies AM, Prywes R, Tzur B et al (1969) The Jerusalem perinatal study. 1. Design and organization of a continuing, community-based, record linked survey. Isr J Med Sci 5:1095–1106PubMed
23.
go back to reference Steinitz R, Parkin DM, Young JL, et al. Cancer incidence in Jewish migrants to Israel, 1961–1981. (1989) In Steinitz R, Parkin DM, Young JL, Bieber CA, Katz L (eds) Vol 98. IARC Sci Publ, pp 6–7 Steinitz R, Parkin DM, Young JL, et al. Cancer incidence in Jewish migrants to Israel, 1961–1981. (1989) In Steinitz R, Parkin DM, Young JL, Bieber CA, Katz L (eds) Vol 98. IARC Sci Publ, pp 6–7
24.
go back to reference International classification of disease for oncology: morphology of neoplasms (2000) 3rd edn International classification of disease for oncology: morphology of neoplasms (2000) 3rd edn
25.
go back to reference Watson P, Lynch HT (2001) Cancer risk in mismatch repair gene mutation carriers. Familial Cancer 1:57–60PubMedCrossRef Watson P, Lynch HT (2001) Cancer risk in mismatch repair gene mutation carriers. Familial Cancer 1:57–60PubMedCrossRef
27.
go back to reference Hoh J, Heitjan DF, Merette C et al (2001) Ascertainment and anticipation in family studies. Hum Hered 51:23–26PubMedCrossRef Hoh J, Heitjan DF, Merette C et al (2001) Ascertainment and anticipation in family studies. Hum Hered 51:23–26PubMedCrossRef
28.
go back to reference King M, Marks JH, (2003) Mandell JB for the New York Breast Cancer Study Group Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2. Science 302:643–645PubMedCrossRef King M, Marks JH, (2003) Mandell JB for the New York Breast Cancer Study Group Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2. Science 302:643–645PubMedCrossRef
29.
go back to reference Bermejo JL, Hemminki K (2005) Familial risk of cancer shortly after diagnosis of the first familial tumor. JNCI 97:1575–9PubMed Bermejo JL, Hemminki K (2005) Familial risk of cancer shortly after diagnosis of the first familial tumor. JNCI 97:1575–9PubMed
30.
go back to reference Wellisch DK, Gritz ER, Schain W et al (1991) Psychological functioning of daughters of breast cancer patients. Part I: Daughters and comparison subjects. Psychosomatics 32:324–336PubMed Wellisch DK, Gritz ER, Schain W et al (1991) Psychological functioning of daughters of breast cancer patients. Part I: Daughters and comparison subjects. Psychosomatics 32:324–336PubMed
31.
go back to reference Lerman C, Daly M, Sands C et al (1993) Mammography adherence and psychological distress among women at risk for breast cancer. J Natl Cancer Inst 85:1074–1080PubMedCrossRef Lerman C, Daly M, Sands C et al (1993) Mammography adherence and psychological distress among women at risk for breast cancer. J Natl Cancer Inst 85:1074–1080PubMedCrossRef
32.
go back to reference Grootenhuis MA, Last BF (1997) Adjustment and coping by parents of children with cancer: a review of the literature. Support Care Cancer 5:466–484PubMedCrossRef Grootenhuis MA, Last BF (1997) Adjustment and coping by parents of children with cancer: a review of the literature. Support Care Cancer 5:466–484PubMedCrossRef
Metadata
Title
The interval between cancer diagnosis among mothers and offspring in a population-based cohort
Authors
Ora Paltiel
Yehiel Friedlander
Lisa Deutsch
Rebecca Yanetz
Ronit Calderon-Margalit
Efrat Tiram
Hagit Hochner
Micha Barchana
Susan Harlap
Orly Manor
Publication date
01-03-2007
Publisher
Kluwer Academic Publishers
Published in
Familial Cancer / Issue 1/2007
Print ISSN: 1389-9600
Electronic ISSN: 1573-7292
DOI
https://doi.org/10.1007/s10689-006-9113-9

Other articles of this Issue 1/2007

Familial Cancer 1/2007 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine